Thyrocalcitonin.
A hormone produced by the thyroid gland, which is believed to regulate the level of calcium in the blood.
Hormone secreted by the thyroid gland; functions in the maintenance of calcium homeostasis by opposing the calcium-mobilizing action of parathormone. It can also serve as a satiety signal.
Hormone secreted by the thyroid gland that regulates the level of calcium in the blood and stimulates bone formation.
A thyroid hormone that lowers plasma calcium and phosphate ion levels by inhibiting bone resorption; increases renal excretion.
A thyroid hormone measured in blood to detect certain types of cancers. The test is done using a radioimmunoassay technique.
A peptide hormone drug prescribed for osteoporosis and Paget disease of the bone. Calcitonin (Calcimar, Miacalcin. Osteocalcin, Salmonine) is a synthetic hormone that is virtually identical to the normal calcitonin found in humans, a hormone secreted by the thyroid gland. The drug slows down the process by which bone is naturally broken down. The calcitonin used in this drug is more potent than human calcitonin and is based on the calcitonin found in salmon.
A hormone, produced by the thyroid gland, which is involved in the metabolism of bone, acting to lower the calcium and phosphate concentrations in the blood. Calcitonin is given by injection in the treatment of some patients with hpercalcaemia (especially when associated with malignant disease). In severe cases of Paget’s disease it is used mainly for pain relief, but also relieves some of the neurological complications such as deafness.
A hormone produced by the human thyroid gland that is important for maintaining a dense, strong bone matrix and regulating the blood calcium level. In patients with medullary carcinoma of the thyroid, calcitonin levels are markedly increased and serve as a tumor marker. Given nasally, salmon calcitonin can be used to treat osteoporosis.
Thyroid gland, a natural endocrine gland within the human body, produces a hormone with therapeutic potential for addressing conditions like osteoporosis and Paget’s bone disease. This hormone, originating from the thyroid gland, possesses the ability to be utilized as a medicinal agent for the treatment of said ailments.
A hormone generated by the thyroid gland, which aids in regulating the levels of calcium in the blood by reducing the rate at which calcium is released from the bones.
A manufactured version of calcitonin administered as a therapeutic measure for Paget’s disease, a condition characterized by abnormal and distorted bone growth leading to pain and an elevated risk of fractures. Injections of synthetic calcitonin typically halt the anomalous bone formation within approximately one week and provide pain relief over the course of a few months.
Calcitonin is additionally employed as a treatment for hypercalcemia, a condition characterized by excessively elevated levels of calcium in the bloodstream. This condition can arise from hyperfunctioning parathyroid glands or bone cancer. By swiftly decreasing the circulating calcium levels in the blood, calcitonin aids in alleviating the symptoms of hypercalcemia, including nausea and vomiting.
Calcitonin is associated with minimal adverse effects. Gastrointestinal responses, such as nausea, vomiting, and diarrhea, generally decrease as treatment continues.